GS 9770
Alternative Names: GS-9770Latest Information Update: 20 May 2024
At a glance
- Originator Gilead Sciences
- Class Antiretrovirals; Small molecules
- Mechanism of Action HIV protease inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical HIV-1 infections